- Home
- KOD vs BKE Comparison
KOD vs BKE Comparison
Compare KOD & BKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | BKE |
|---|---|---|
| Founded | 2009 | 1948 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.2B |
| IPO Year | 2018 | 1996 |
Fundamental Metrics
Financial Performance| Metric | KOD | BKE |
|---|---|---|
| Price | $42.83 | $44.46 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 1 |
| Target Price | $35.43 | ★ $53.00 |
| AVG Volume (30 Days) | ★ 506.3K | 400.0K |
| Earning Date | 05-14-2026 | 05-22-2026 |
| Dividend Yield | N/A | ★ 7.96% |
| EPS Growth | N/A | ★ 6.43 |
| EPS | N/A | ★ 0.92 |
| Revenue | N/A | ★ $1,297,835,000.00 |
| Revenue This Year | N/A | $5.10 |
| Revenue Next Year | N/A | $4.99 |
| P/E Ratio | ★ N/A | $49.26 |
| Revenue Growth | N/A | ★ 6.58 |
| 52 Week Low | $8.29 | $40.73 |
| 52 Week High | $47.84 | $61.69 |
Technical Indicators
Market Signals| Indicator | KOD | BKE |
|---|---|---|
| Relative Strength Index (RSI) | 53.30 | 51.07 |
| Support Level | $38.72 | $41.15 |
| Resistance Level | $45.23 | $45.81 |
| Average True Range (ATR) | 2.55 | 1.09 |
| MACD | -0.10 | 0.11 |
| Stochastic Oscillator | 52.84 | 49.73 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc has developed a new technology platform, the Antibody Biopolymer Conjugate (ABC) platform, for retinal medicines. Its investigational medicine, tarcocimab tedromer (Zenkuda or tarcocimab), is an anti-VEGF therapy built on Kodiak's proprietary ABC platform. Another investigational medicine, KSI-501, is an anti-interleukin 6, or IL-6, VEGF-trap bispecific therapy built on the ABC platform and is being developed for high-prevalence retinal vascular diseases and intended to address the unmet needs of extended durability and targeting disease biology beyond VEGF for differentiated efficacy. Its third investigational medicine, KSI-101, is a high-strength (100 mg/mL) bispecific protein targeting IL-6 and VEGF.
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.